Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1-high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part1.
Saved in:
| Title: | Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1-high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part1. |
|---|---|
| Authors: | Naidoo J; Department of Medicine, Beaumont Hospital Dublin, RCSI University of Medicine and Health Science, Dublin, Ireland. Electronic address: jarushkanaidoo@beaumont.ie., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch., Runglodvatana Y; Division of Medical Oncology, Department of Internal Medicine, Vajira Hospital, Bangkok, Thailand. Electronic address: kanakorn@nmu.ac.th., Li JY; Department of Clinical Oncology, Hong Kong United Oncology Centre, Kowloon, Hong Kong, China. Electronic address: ycli@hkuoc.hk., Fong CH; Department of Radiotherapy and Oncology, Hospital Pulau Pinang, Penang, Malaysia. Electronic address: fongchinheng@gmail.com., Ho GF; Clinical Oncology Unit, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. Electronic address: gfho@curieoncology.com.my., How SH; Department of Medicine, Hospital Tengku Ampuan Afzan, Pahang, Malaysia. Electronic address: how_sh@yahoo.com., Juengsamarn J; Oncology Unit, Department of Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand. Electronic address: jittyjungnut@gmail.com., Graham JR; Arcus Biosciences, Inc., Hayward, CA, United States. Electronic address: jgraham@arcusbio.com., Marina N; Arcus Biosciences, Inc., Hayward, CA, United States. Electronic address: nmsmarina@gmail.com., Dang T; Gilead Sciences, Inc., Foster City, CA, United States. Electronic address: thao.dang1@gilead.com., Patel D; Arcus Biosciences, Inc., Hayward, CA, United States. Electronic address: pat.deepa.s@gmail.com., Han S; Arcus Biosciences, Inc., Hayward, CA, United States. Electronic address: shan@arcusbio.com., Bermingham C; Arcus Biosciences, Inc., Hayward, CA, United States. Electronic address: cbermingham@arcusbio.com., Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, United States. Electronic address: melissa.johnson@scri.com. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 May; Vol. 215, pp. 109316. Date of Electronic Publication: 2026 Feb 11. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
